Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Rank in Stocks #40631
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Share Price
$0.00045794
Last synced: 2025-07-11
Market Cap
$107.51K
Change (1 day)
-36.01%
Change (1 year)
0.00%
Country
DK
Trade Scandion Oncology A/S (SCOL)

Category

Stock split history for Scandion Oncology A/S (SCOL)
Scandion Oncology A/S stock (symbol: SCOL) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One SCOL share bought prior to Aug 13, 2026 would equal to 0 SCOL shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE